Met Life Investment Management, LLC Frequency Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $82,802 - $119,420	-10,286 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$7.99 - $55.01 $82,185 - $565,832	10,286 New	10,286 $97,000
Q1 2021 Jun 26, 2023	BUY	$7.99 - $55.01 $82,185 - $565,832	10,286 New	10,286 $97.7 Million
Q4 2020 May 24, 2024	SELL	$18.65 - $40.0 $50,709 - $108,760	-2,719 Reduced 20.91%	10,286 $362,000
Q4 2020 Jun 22, 2023	BUY	$18.65 - $40.0 $191,833 - $411,440	10,286 New	10,286 $362,000
Q4 2020 Mar 22, 2023	SELL	$18.65 - $40.0 $50,709 - $108,760	-2,719 Reduced 20.91%	10,286 $362,000
Q4 2020 Feb 16, 2021	SELL	$18.65 - $40.0 $50,709 - $108,760	-2,719 Reduced 20.91%	10,286 $363,000
Q3 2020 Jun 26, 2023	BUY	$17.76 - $24.96 $230,968 - $324,604	13,005 New	13,005 $249,000
Q2 2020 May 24, 2024	BUY	$14.65 - $24.9 $190,523 - $323,824	13,005 New	13,005 $302 Million
Q2 2020 Jun 26, 2023	BUY	$14.65 - $24.9 $190,523 - $323,824	13,005 New	13,005 $302,000
Q2 2020 Mar 22, 2023	BUY	$14.65 - $24.9 $190,523 - $323,824	13,005 New	13,005 $302,000
Q2 2020 Aug 14, 2020	BUY	$14.65 - $24.9 $190,523 - $323,824	13,005 New	13,005 $302,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.